Andrew D. Kelly
- Co-authors
- Jean‐Pierre J. IssaDimitrios SpentzosJaroslav Jelı́nekBela PatelJeffrey D. GoldsmithJozef MadžoCharly R. GoodShoghag Panjarian
- Topics
- Epigenetics and DNA Methylation (8 papers)Cancer Genomics and Diagnostics (8 papers)Acute Myeloid Leukemia Research (5 papers)
- Partner nations
- United StatesAustraliaCanada
In The Last Decade
Andrew D. Kelly
22 papers receiving 653 citations
Peers
Comparison fields: 5 of 89
- Molecular Biology 502
- Cancer Research 253
- Pulmonary and Respiratory Medicine 120
- Oncology 79
- Genetics 40
Countries citing papers authored by Andrew D. Kelly
This map shows the geographic impact of Andrew D. Kelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew D. Kelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew D. Kelly more than expected).
Fields of papers citing papers by Andrew D. Kelly
This network shows the impact of papers produced by Andrew D. Kelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew D. Kelly. The network helps show where Andrew D. Kelly may publish in the future.
Co-authorship network of co-authors of Andrew D. Kelly
This figure shows the co-authorship network connecting the top 25 collaborators of Andrew D. Kelly. A scholar is included among the top collaborators of Andrew D. Kelly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew D. Kelly. Andrew D. Kelly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 25 | |
| 3 | 9 | |
| 4 | 3 | |
| 5 | 10 | |
| 6 | 20 | |
| 7 | 108 | |
| 8 | 7 | |
| 9 | 28 | |
| 10 | 118 | |
| 11 | 33 | |
| 12 | 68 | |
| 13 | 29 | |
| 14 | 89 | |
| 15 | 23 | |
| 16 | 4 | |
| 17 | 59 | |
| 18 | 7 | |
| 19 | A generic object-oriented incremental analyser for constraint logic programs | 1 |
| 20 | Effectiveness of Optimizing Compilation for CLP(R). | 7 |
About Andrew D. Kelly
Andrew D. Kelly is a scholar working on Cancer Research, Hematology and Software, having authored 23 papers that have together received 658 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (8 papers), Cancer Genomics and Diagnostics (8 papers) and Acute Myeloid Leukemia Research (5 papers). The work is most often cited by research in Cancer Research (253 citations), Molecular Biology (502 citations) and Pulmonary and Respiratory Medicine (120 citations). Andrew D. Kelly has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Jean‐Pierre J. Issa, Dimitrios Spentzos, Jaroslav Jelı́nek, Bela Patel, Jeffrey D. Goldsmith, Jozef Madžo, Charly R. Good, Shoghag Panjarian, Katherine E. Hill and John M. Asara. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.